text_1: Nanoparticles can be targeted against specific cell types by incorporating aptamers into lipid nanoparticles.
text_2: Currently, major concerns about the safety and efficacy of RNA interference (RNAi)-based bone anabolic strategies still exist because of the lack of direct osteoblast-specific delivery systems for osteogenic siRNAs.